🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To observe and evaluate the efficacy and safety of FOLFOX/FOLFIRI± target-d...
Status
Unknown
Location
Liaoning Cancer Hospital & Institute
Start Date
2022-08-01
Trial ID
NCT05797883
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
The purpose of this study is to verify the efficacy of mFOLFOX6 + panitumum...
Status
Completed
Location
Multiple Locations
Start Date
2015-05-29
Trial ID
NCT02394795
This is a prospective, multicenter, randomized controlled, phase II study. ...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07621497
This randomized phase II trial studies how well combination chemotherapy an...
Status
Withdrawn
Location
USC Norris Comprehensive Cancer Center
Start Date
2015-11
Trial ID
NCT02413853
Immune therapies work with the body's immune system to treat a number of ca...
Status
Terminated
Location
Providence Medical Foundation
Start Date
2021-10-19
Trial ID
NCT05083481
This phase II trial will investigate the combination of adjuvant 5-fluorour...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2006-03
Trial ID
NCT00308516
Treatments Being Tested
The purpose of this study is to investigate biomarkers which may be predict...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-05-29
Trial ID
NCT02394834
To determine the effect of ABT-869 plus mFOLFOX6 compared to bevacizumab pl...
Status
Completed
Location
Site Reference ID/Investigator# 11341
Start Date
2008-10
Trial ID
NCT00707889
Treatments Being Tested
ASP1002 is being studied in people with tumors that have spread to nearby t...
Status
Recruiting
Location
Yale University Cancer Center
Start Date
2023-03-13
Trial ID
NCT05719558